OSTX
OS Therapies Incorporated
0.8722
-0.04 (-4.48%)
52w low 0.5800
2.25 high
17.5% of range
Financial Analysis
| Ratio | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on Equity | -- | 35.6% | 32.4% | 271.9% | 471.7% | |
| Return on Assets | -- | -1,228.6% | -976.3% | -160.4% | -420.4% | |
| Return on Inv Capital | -- | 48.7% | 36.5% | 165.2% | 372.7% | |
| Liquidity | ||||||
| Current Ratio | -- | 0.08x | 0.03x | 1.20x | 0.03x | |
| Quick Ratio | -- | 0.08x | 0.03x | 1.20x | 0.03x | |
| Cash Ratio | -- | 0.03x | 0.00x | 1.20x | 0.02x | |
| Leverage | ||||||
| Debt / Equity | -- | -0.59x | -0.61x | -- | -- | |
| Net Debt / EBITDA | -- | -2.29x | -3.36x | -- | -- | |
| Interest Coverage | -- | -2.46x | -1.26x | -3.33x | -- | |
| Equity Multiplier | -- | -0.03x | -0.03x | -1.70x | -1.12x | |
| Efficiency | ||||||
| Asset Turnover | -- | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | -- | 0.61x | 0.39x | 0.82x | 0.50x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--